Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Suppression of plasma 6-keto-prostaglandin F1 alpha and 13,14-dihydro-15-keto-prostaglandin F2 alpha by aminoglutethimide in advanced breast cancer.

× No keyword cloud information.

28 in total

1. Is the sheep corpus luteum subject to tonic inhibition during the luteal phase of the estrous cycle?

Authors: J S Robinson; J R Challis; B J Furr; T M Louis; G D Thorburn
Journal: Eur J Obstet Gynecol Reprod Biol Date: 1976 Impact factor: 2.435

2. Human breast tumour-induced osteolysis and prostaglandins.

Authors: M Dowsett; G C Easty; T J Powles; D M Easty; A M Neville
Journal: Prostaglandins Date: 1976-03

3. Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro.

Authors: L G Raisz; J W Dietrich; H A Simmons; H W Seyberth; W Hubbard; J A Oates
Journal: Nature Date: 1977-06-09 Impact factor: 49.962

4. The effect of endogenous and exogenous estradiol-17beta on the release of prostaglandin F2alpha from the ovine uterus.

Authors: B Barcikowski; J C Carlson; L Wilson; J A McCracken
Journal: Endocrinology Date: 1974-11 Impact factor: 4.736

5. Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action.

Authors: R N Dexter; L M Fishman; R L Ney; G W Liddle
Journal: J Clin Endocrinol Metab Date: 1967-04 Impact factor: 5.958

6. The effects of exogenous progesterone and estradiol on prostaglandin F levels in ovariectomized ewes.

Authors: B V Caldwell; S A Tillson; W A Brock; L Speroff
Journal: Prostaglandins Date: 1972-03

7. Evidence suggesting 11 beta-hydroxylase inhibition during aminoglutethimide administration.

Authors: G Faglia; L Gattinoni; P Travaglini; V Neri; L Acerbi; B Ambrosi
Journal: Metabolism Date: 1971-03 Impact factor: 8.694

8. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.

Authors: T J Powles; M Dowsett; G C Easty; D M Easty; A M Neville
Journal: Lancet Date: 1976-03-20 Impact factor: 79.321

9. Production of prostaglandins by the pseudopregnant rat uterus, in vitro, and the effect of tamoxifen with the identification of 6-keto-prostaglandin F1alpha as a major product.

Authors: L Fenwick; R L Jones; B Naylor; N L Poyser; N H Wilson
Journal: Br J Pharmacol Date: 1977-01 Impact factor: 8.739

10. Breast cancer, prostaglandins, and bone metastases.

Authors: A Bennett; A M McDonald; J S Simpson; I F Stamford
Journal: Lancet Date: 1975-05-31 Impact factor: 79.321

6 in total

Review 1. Could aminoglutethimide replace adrenalectomy?

Authors: A L Harris
Journal: Breast Cancer Res Treat Date: 1985 Impact factor: 4.872

Review 2. Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors: P E Lønning; S Kvinnsland
Journal: Drugs Date: 1988-06 Impact factor: 9.546

Review 3. Aromatase inhibitors in malignant diseases of aging.

Authors: D C Johannessen; P E Lønning
Journal: Drugs Aging Date: 1992 Nov-Dec Impact factor: 3.923

4. The effects of aminoglutethimide and hydrocortisone, alone and combined, on androgen levels in post-orchiectomy prostatic cancer patients.

Authors: M Dowsett; R J Shearer; B A Ponder; P Malone; S L Jeffcoate
Journal: Br J Cancer Date: 1988-02 Impact factor: 7.640

5. Aromatase inhibition: 4-hydroxyandrostenedione (4-OHA, CGP 32349) in advanced prostatic cancer.

Authors: J H Davies; M Dowsett; S Jacobs; R C Coombes; A Hedley; R J Shearer
Journal: Br J Cancer Date: 1992-07 Impact factor: 7.640

6. Response to aminoglutethimide and cortisone acetate in advanced prostatic cancer.

Authors: B A Ponder; R J Shearer; R D Pocock; J Miller; D Easton; C E Chilvers; M Dowsett; S L Jeffcoate
Journal: Br J Cancer Date: 1984-12 Impact factor: 7.640

6 in total